Clinical trial
A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
NCT00422162 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00422162 |
|---|---|
| Title | A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression |
| Official title | An Eight-Week, Randomized, Double Blind, Two Parallel Groups, Study to Assess Clinical Response of Duloxetine 60 mg and 120 Per Day in Patients Hospitalized for Severe Depression |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Duloxetine hydrochloride, Placebo |
| Enrollment | 339 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jan 15, 2007 |
| Last update posted | Jul 26, 2011 |
| Countries | France, Italy, Russia, South Africa |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: